Kyleena 19.5 MG systems
Ended Awarded
- Contract number
- SPE2DB25FDM30
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,321
Award facts
- Contract value 100% obligated
- $12,321.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,321.00 by the Defense Logistics Agency (DLA) on September 26, 2025, for Kyleena 19.5 mg contraceptive systems. The delivery order, which carries no set-aside designation, is scheduled for completion by October 20, 2025, with performance at the contractor's Park Ridge facility. This award represents a discrete delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities.
DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain through consistent delivery of branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to military health facilities nationwide. The company's extensive contract portfolio with the DLA demonstrates its capability to fulfill diverse pharmaceutical procurement requirements, ranging from contraceptive devices to specialized oncology and injectable products. As a woman-owned small business registered in SAM.gov since 2001, the contractor leverages its federal experience and established relationship with the DLA to compete effectively in the competitive federal procurement marketplace while supporting critical medical supply needs across the Department of Defense.
Quick answers
Who was awarded contract SPE2DB25FDM30?
SPE2DB25FDM30 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FDM30 worth?
The government has obligated $12,321 on SPE2DB25FDM30.
Is contract SPE2DB25FDM30 an order under another contract?
Yes. SPE2DB25FDM30 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDM30 competed?
The extent of competition for SPE2DB25FDM30 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award